Abstract
The infectious novel coronavirus disease COVID-19 outbreak has been declared as a public health emergency of international concern, and later as an epidemic. To date, this outbreak has infected more than one million people and killed over fifty thousand people across the world. In most countries, the COVID-19 incidence curve rises sharply in a short span of time, suggesting a transition from a disease free (or low-burden disease) equilibrium state to a sustained infected (or high-burden disease) state. Such a transition from one stable state to another state in a relatively short span of time is often termed as a critical transition. Critical transitions can be, in general, successfully forecasted using many statistical measures such as return rate, variance and lag-1 autocorrelation. Here, we report an empirical test of this forecasting on the COVID-19 data sets for nine countries including India, China and the United States. For most of the data sets, an increase in autocorrelation and a decrease in return rate predict the onset of a critical transition. Our analysis suggests two key features in predicting the COVID-19 incidence curve for a specific country: a) the timing of strict social distancing and/or lockdown interventions implemented, and b) the fraction of a nation’s population being affected by COVID-19 at the time of implementation of these interventions. Further, using satellite data of nitrogen dioxide which is emitted predominantly as a result of anthropogenic activities, as an indicator of lockdown policy, we find that in countries where the lockdown was implemented early and strictly have been successful in reducing the extent of transmission of the virus. These results hold important implications for designing effective strategies to control the spread of infectious pandemics.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
S.S. acknowledges the financial support from the Department of Science & Technology (DST), Govt. of India under the scheme DST-Inspire [Grant No.: IF160459]. P.S.D. acknowledges financial support from the Science & Engineering Research Board (SERB), Govt. of India [Grant No.: CRG/2019/002402].
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.